ImmuPharma plc (LON:IMM – Get Free Report) shares dropped 7.8% during mid-day trading on Friday . The stock traded as low as GBX 4.33 and last traded at GBX 4.33. Approximately 461,123 shares changed hands during trading, a decline of 85% from the average daily volume of 3,016,400 shares. The stock had previously closed at GBX 4.70.
ImmuPharma Trading Down 8.3%
The firm has a market cap of £26.86 million, a P/E ratio of -4.84 and a beta of 2.98. The company’s 50 day simple moving average is GBX 4.77 and its 200-day simple moving average is GBX 6.44.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Read More
- Five stocks we like better than ImmuPharma
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
